Viewing StudyNCT00003561



Ignite Creation Date: 2024-05-05 @ 11:08 AM
Last Modification Date: 2024-10-26 @ 9:03 AM
Study NCT ID: NCT00003561
Status: TERMINATED
Last Update Posted: 2011-07-20
First Post: 1999-11-01

Brief Title: Interferon Alfa Plus Sargramostim in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Conditions & Keywords Data

Conditions:
Name
Leukemia
Keywords:
Name View
chronic phase chronic myelogenous leukemia View
Philadelphia chromosome positive chronic myelogenous leukemia View
Philadelphia chromosome negative chronic myelogenous leukemia View